These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24585545)

  • 41. Novel FISH probes designed to detect IGK-MYC and IGL-MYC rearrangements in B-cell lineage malignancy identify a new breakpoint cluster region designated BVR2.
    Einerson RR; Law ME; Blair HE; Kurtin PJ; McClure RF; Ketterling RP; Flynn HC; Dogan A; Remstein ED
    Leukemia; 2006 Oct; 20(10):1790-9. PubMed ID: 16888615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma.
    Kaufmann H; Ackermann J; Baldia C; Nösslinger T; Wieser R; Seidl S; Sagaster V; Gisslinger H; Jäger U; Pfeilstöcker M; Zielinski C; Drach J
    Leukemia; 2004 Nov; 18(11):1879-82. PubMed ID: 15385925
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene.
    Richelda R; Ronchetti D; Baldini L; Cro L; Viggiano L; Marzella R; Rocchi M; Otsuki T; Lombardi L; Maiolo AT; Neri A
    Blood; 1997 Nov; 90(10):4062-70. PubMed ID: 9354676
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Submicroscopic deletions of immunoglobulin heavy chain gene (IGH) in precursor B lymphoblastic leukemia with IGH rearrangements.
    Huh J; Mun YC; Yoo ES; Seong CM; Chung WS
    Ann Lab Med; 2015 Jan; 35(1):128-31. PubMed ID: 25553293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.
    Gabrea A; Bergsagel PL; Chesi M; Shou Y; Kuehl WM
    Mol Cell; 1999 Jan; 3(1):119-23. PubMed ID: 10024885
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia.
    Nowakowski GS; Dewald GW; Hoyer JD; Paternoster SF; Stockero KJ; Fink SR; Smoley SA; Remstein ED; Phyliky RL; Call TG; Shanafelt TD; Kay NE; Zent CS
    Br J Haematol; 2005 Jul; 130(1):36-42. PubMed ID: 15982342
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of illegitimate rearrangements within the immunoglobulin light chain loci in B cell malignancies using end sequenced probes.
    Poulsen TS; Silahtaroglu AN; Gisselø CG; Tommerup N; Johnsen HE
    Leukemia; 2002 Oct; 16(10):2148-55. PubMed ID: 12357370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Primary pulmonary MALT lymphomas show frequent and heterogeneous cytogenetic abnormalities, including aneuploidy and translocations involving API2 and MALT1 and IGH and MALT1.
    Remstein ED; Kurtin PJ; Einerson RR; Paternoster SF; Dewald GW
    Leukemia; 2004 Jan; 18(1):156-60. PubMed ID: 14574335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization.
    Taniwaki M; Nishida K; Ueda Y; Misawa S; Nagai M; Tagawa S; Yamagami T; Sugiyama H; Abe M; Fukuhara S
    Blood; 1995 Jun; 85(11):3223-8. PubMed ID: 7756653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery platform for inhibitors of IgH gene enhancer activity.
    Dolloff NG
    Cancer Biol Ther; 2019; 20(4):571-581. PubMed ID: 30481117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
    Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular cytogenetic analysis of chromosomal breakpoints in the IGH, MYC, BCL6, and MALT1 gene loci in primary cutaneous B-cell lymphomas.
    Hallermann C; Kaune KM; Gesk S; Martin-Subero JI; Gunawan B; Griesinger F; Vermeer MH; Santucci M; Pimpinelli N; Willemze R; Siebert R; Neumann C
    J Invest Dermatol; 2004 Jul; 123(1):213-9. PubMed ID: 15191563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
    Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
    Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
    Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
    Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
    Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
    Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
    Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
    Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies.
    Nakazawa N; Nishida K; Tamura A; Kobayashi M; Iwai T; Horiike S; Nishigaki H; Otsuki T; Tomiyama Y; Fujii H; Kashima K; Taniwaki M
    Cancer Genet Cytogenet; 2000 Mar; 117(2):89-96. PubMed ID: 10704676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of the rate of detection of immunoglobulin heavy chain gene rearrangement by fluoresecence in situ hybridization probes in multiple myeloma.].
    Chung HY; See CJ; Choi JE; Min HJ; Cho HI; Lee DS
    Korean J Lab Med; 2006 Oct; 26(5):317-22. PubMed ID: 18156744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of High-risk Cryptic CRLF2 Rearrangements in B-Cell Acute Lymphoblastic Leukemia Utilizing an FGFR3/IGH Dual-Color Dual-Fusion DNA Probe Set.
    Robin AJ; Peterson JF; Grignon JW; Gheorghe G; Burke MJ; vanTuinen P
    J Pediatr Hematol Oncol; 2017 May; 39(4):e207-e210. PubMed ID: 27820126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.